Additionally, another recent study shows that COL1A1 inhibition in glioma cells decreased CD68+ and IBA1+ macrophages/microglia within the tumor, decreased mesenchymal transformation, and inhibited tumor growth (36). This evidence concerns the gene CD68 and neoplasm.